The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hetronifly (serplulimab) to treat adults ...

At a time when Novo Nordisk has appeared to be slipping behind rival Eli Lilly and its blockbuster Zepbound (tirzepatide) in ...

Private Equity - a subsidiary of Turkey's İşbank Group - has committed $39 million to a Harvard University research lab to ...

US healthcare group Abbott (NYSE: ABT) has signed a wide-ranging agreement with health authorities in Abu Dhabi to localize ...

Zealand Pharma, a Danish firm focused on the discovery and development of innovative peptide-based medicines, has announced ...

Danish vaccine specialist Bavarian Nordic (OMX: BAVA) is set to collect $160 million from the sale of a US priority review ...

China is preparing to ease access to its capital markets for early-stage biotech companies, signaling what could be a turning ...

Japanese drugmaker Mochida Pharmaceutical (TYO: 4534) announced that Thien Thao Pharmaceutical Joint Stock Company, a partner ...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted UK pharma major GSK’s regulatory application to expand the ...

A reshaped agenda for the Centers for Disease Control and Prevention’s vaccine advisory committee meeting on June 25–26 ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

Further expanding the indications for French pharma major Sanofi’s (Euronext: SAN) mega-blockbuster Dupixent (dupilumab), the ...